Drugs / BIOD-123
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01908894 | Feb → Mar 2012 | diabetes mellitus | Biodel | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01686620 | Aug 2012 → Jun 2013 | type 1 diabetes mellitus | Biodel | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIOD-123 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01908894 ↗ |